Engineered enzyme for a diabetes drug
Savile and colleagues evolved a transaminase enzyme to make the drug sitagliptin, replacing a metal-catalysed step in manufacturing.
Built / tested: pharmaceutical manufacturing process
As reported in: Savile, Janey, Mundorff et al. (2010). Biocatalytic Asymmetric Synthesis of Chiral Amines from Ketones Applied to Sitagliptin Manufacture. Science. doi:10.1126/science.1188934
Abstract only